Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Advanced endometrial clear cell carcinoma (CCC) tends to have poor prognosis owing to aggressive clinical behavior and poor response to conventional chemotherapy. Herein, we report a case of platinum-refractory recurrent ECCC successfully treated with the combination of pembrolizumab, localized radiotherapy and a few cycles of chemotherapy with an extremely durable response even after cessation of immunotherapy for 3 years at the time of publication.

Cite

CITATION STYLE

APA

Kao, C. H., Liu, C. T., Lin, H., Huang, Y. C., Lan, J., Ou, Y. C., … Wu, C. H. (2022). Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1079253

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free